Daniel S. Pearson

4.6k total citations
16 papers, 920 citations indexed

About

Daniel S. Pearson is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Daniel S. Pearson has authored 16 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Cancer Research. Recurrent topics in Daniel S. Pearson's work include MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). Daniel S. Pearson is often cited by papers focused on MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). Daniel S. Pearson collaborates with scholars based in United States and Germany. Daniel S. Pearson's co-authors include Kasey C. Vickers, Praveen Sethupathy, Francis S. Collins, George Q. Daley, Han Wu, Bassem M. Shoucri, David O. Osei-Hwedieh, Michael G. Levin, Alan T. Remaley and Katherine Kacena and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Daniel S. Pearson

14 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel S. Pearson United States	9	623	345	181	135	126	16	920
Hannie Sietsma Netherlands	19	751 1.2×	109 0.3×	86 0.5×	132 1.0×	40 0.3×	22	1.0k
KangAe Lee United States	6	444 0.7×	391 1.1×	54 0.3×	119 0.9×	24 0.2×	6	832
Deborah A. Lazzarino United States	15	584 0.9×	184 0.5×	112 0.6×	156 1.2×	17 0.1×	19	872
Brooke B. Ancrile United States	7	356 0.6×	106 0.3×	114 0.6×	105 0.8×	162 1.3×	8	749
Shigeru Daido Japan	9	577 0.9×	160 0.5×	92 0.5×	132 1.0×	58 0.5×	17	966
Daniela Flügel Germany	9	452 0.7×	377 1.1×	111 0.6×	79 0.6×	14 0.1×	9	739
Abbas Shakoori Iran	16	1.1k 1.7×	313 0.9×	49 0.3×	146 1.1×	14 0.1×	48	1.3k
Hassan Hall United States	11	954 1.5×	224 0.6×	82 0.5×	336 2.5×	17 0.1×	11	1.1k
Xiuying Zhong China	13	814 1.3×	564 1.6×	75 0.4×	52 0.4×	16 0.1×	16	1.1k
Alessandra Trencia Italy	9	582 0.9×	109 0.3×	70 0.4×	89 0.7×	25 0.2×	9	728

Countries citing papers authored by Daniel S. Pearson

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Pearson more than expected).

Fields of papers citing papers by Daniel S. Pearson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Pearson. The network helps show where Daniel S. Pearson may publish in the future.

Co-authorship network of co-authors of Daniel S. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Pearson. A scholar is included among the top collaborators of Daniel S. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Pearson. Daniel S. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Yatim, Karim, Ayman Al Jurdi, Christopher El Mouhayyar, et al.. (2024). Safety and Efficacy of a Preemptive Mycophenolate Mofetil Dose Reduction Strategy in Kidney Transplant Recipients. Transplantation Direct. 10(9). e1697–e1697.

2.

Pearson, Daniel S., Dustin McEvoy, Mandakolathur R. Murali, & Anand S. Dighe. (2023). Use of Clinical Decision Support to Improve the Laboratory Evaluation of Monoclonal Gammopathies. American Journal of Clinical Pathology. 159(2). 192–204. 1 indexed citations

3.

Yamamoto, Takayuki, Daniel S. Pearson, Emad Ababneh, et al.. (2022). Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch. PubMed. 2. 1047217–1047217.

4.

Osborne, Jihan K., Melissa A. Kinney, Areum Han, et al.. (2021). Lin28 paralogs regulate lung branching morphogenesis. Cell Reports. 36(3). 109408–109408. 4 indexed citations

5.

Han, Areum, Alena Yermalovich, Vanessa Lundin, et al.. (2020). An Essential Role for the RNA Editor-Exonuclease Axis in Terminal Erythroid Differentiation. Blood. 136(Supplement 1). 3–3. 1 indexed citations

6.

Yu, Chunxiao, Longfei Wang, R. Grant Rowe, et al.. (2020). A nanobody targeting the LIN28:let-7 interaction fragment of TUT4 blocks uridylation of let-7. Proceedings of the National Academy of Sciences. 117(9). 4653–4663. 15 indexed citations

7.

Wang, Longfei, R. Grant Rowe, Chunxiao Yu, et al.. (2018). Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28. Cell Reports. 23(10). 3091–3101. 90 indexed citations

8.

Powers, John T., Kaloyan M. Tsanov, Daniel S. Pearson, et al.. (2016). Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature. 535(7611). 246–251. 138 indexed citations

9.

Tsanov, Kaloyan M., Daniel S. Pearson, Zhaoting Wu, et al.. (2016). LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency. Nature Cell Biology. 19(1). 60–67. 55 indexed citations

10.

Rowe, R. Grant, Leo D. Wang, Sílvia Coma, et al.. (2016). Developmental regulation of myeloerythroid progenitor function by the Lin28b–let-7–Hmga2 axis. The Journal of Experimental Medicine. 213(8). 1497–1512. 55 indexed citations

11.

Kurtz, C. Lisa, Emily E. Fannin, Cynthia L. Toth, et al.. (2015). Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Scientific Reports. 5(1). 12911–12911. 67 indexed citations

12.

Vickers, Kasey C., Bassem M. Shoucri, Michael G. Levin, et al.. (2012). Microrna-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia. Hepatology. 57(2). 533–542. 192 indexed citations

13.

Vickers, Kasey C., Bassem M. Shoucri, Michael G. Levin, et al.. (2012). Abstract 24: MicroRNA-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia. Arteriosclerosis Thrombosis and Vascular Biology. 32(suppl_1). 2 indexed citations

14.

Stitzel, Michael L., Praveen Sethupathy, Daniel S. Pearson, et al.. (2010). Global Epigenomic Analysis of Primary Human Pancreatic Islets Provides Insights into Type 2 Diabetes Susceptibility Loci. Cell Metabolism. 12(5). 443–455. 136 indexed citations

15.

Bultron, Gilberto, Katherine Kacena, Daniel S. Pearson, et al.. (2010). The risk of Parkinson's disease in type 1 Gaucher disease. Journal of Inherited Metabolic Disease. 33(2). 167–173. 161 indexed citations

16.

Stitzel, Michael L., Praveen Sethupathy, Daniel S. Pearson, et al.. (2010). Global Epigenomic Analysis of Primary Human Pancreatic Islets Provides Insights into Type 2 Diabetes Susceptibility Loci. Cell Metabolism. 12(6). 683–683. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact